Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World 2024-01-25 18:38
Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World 2024-01-25 18:00
Asieris will Present For the First Time Interim Analysis Data of Oral APL-1202 in Combination with PD-1 Inhibitor Tislelizumab for Neoadjuvant Treatment of Muscle-Invasive Bladder Cancer at 2024 ASCO-GU 2024-01-25 16:56
Empowering Communities - Summit Planners launches Will Planning Seminars for the members of the public. 2024-01-25 11:53
Alphamab Oncology and 3DMedicines Entered into a Licensing Agreement with Glenmark for KN035 2024-01-25 10:40
PS128 Successfully Targets Behavioral and Emotional Challenges in Autism Spectrum Disorder (ASD): Completion of Pivotal Clinical Trial on Preschool Children with ASD 2024-01-25 10:00
WuXi Biologics Launches WuXia ADCC PLUS™ for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC Effect 2024-01-25 08:30
icotec ag raises $30m in growth financing from MVM Partners 2024-01-25 01:45
FDA purchases digiM I2S software for the assessment of product quality attributes 2024-01-24 23:37
ŸNSECT GRANTED FIRST APPROVAL OF ITS KIND, TO COMMERCIALISE MEALWORM PROTEINS FOR DOG FOOD IN THE USA 2024-01-24 22:09
Wellysis Goes Global with ECG Monitor 'S-Patch', Enters US and Indian Markets 2024-01-24 22:00
WestGene Spearheads Oncology Breakthroughs at the 3rd mRNA-Based Therapeutics Summit 2024-01-24 21:32
Positive Xanamem® human PET study published in the Journal of Alzheimer's Disease demonstrating robust CNS[1] target enzyme occupancy 2024-01-24 21:30
Genome & Company Announces Positive Topline Results from Phase 2 Clinical Trial of Combination of GEN-001 and Bavencio® for the Treatment of Gastric Cancer Poster presented at ASCO GI 2024-01-24 21:00
Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases' 2024-01-24 20:00
SHL Medical partners with SteriPack Group to set up final assembly service 2024-01-24 18:00
Sirnaomics Publishes Novel Mechanism of Action of RNAi Cancer Therapeutic STP707 for Solid Tumors 2024-01-24 17:49
Ascletis Announces Dosing of the First Patient in Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne 2024-01-24 16:50
PRISM BioLab raises 1.5 billion yen in Series C fundraising to advance technologies and programs targeting protein-protein interactions 2024-01-24 16:00
Onward Therapeutics Announces Enrollment of Phase 1 Clinical Trial of a Novel Bispecific Antibody (OT-A201) Targeting Two Immune Checkpoints 2024-01-24 15:00
1 138 139 140 141 142 1600